Citadel Advisors’s Evoke Pharma EVOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33K | Sell |
12,542
-12,261
| -49% | -$32.2K | ﹤0.01% | 5555 |
|
|
2025
Q1 | $68.2K | Buy |
+24,803
| New | +$68.2K | ﹤0.01% | 5276 |
|
|
2024
Q3 | – | Sell |
-993
| Closed | -$6.3K | – | 6028 |
|
|
2024
Q2 | $6.3K | Buy |
+993
| New | +$6.3K | ﹤0.01% | 5563 |
|
|
2022
Q1 | – | Sell |
-185
| Closed | -$15K | – | 6561 |
|
|
2021
Q4 | $15K | Sell |
185
-91
| -33% | -$7.38K | ﹤0.01% | 6337 |
|
|
2021
Q3 | $52K | Buy |
276
+4
| +1% | +$754 | ﹤0.01% | 6105 |
|
|
2021
Q2 | $54K | Buy |
+272
| New | +$54K | ﹤0.01% | 6181 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6385 |
|
|
2020
Q4 | – | Sell |
-159
| Closed | -$108K | – | 5197 |
|
|
2020
Q3 | $108K | Buy |
+159
| New | +$108K | ﹤0.01% | 4238 |
|
|
2020
Q2 | – | Sell |
-185
| Closed | -$31K | – | 4812 |
|
|
2020
Q1 | $31K | Buy |
+185
| New | +$31K | ﹤0.01% | 4609 |
|
|
2019
Q3 | – | Sell |
-410
| Closed | -$37K | – | 4792 |
|
|
2019
Q2 | $37K | Buy |
+410
| New | +$37K | ﹤0.01% | 4404 |
|
|
2018
Q1 | – | Sell |
-81
| Closed | -$26K | – | 4076 |
|
|
2017
Q4 | $26K | Buy |
+81
| New | +$26K | ﹤0.01% | 3737 |
|
|
2017
Q1 | – | Sell |
-116
| Closed | -$34K | – | 3774 |
|
|
2016
Q4 | $34K | Buy |
+116
| New | +$34K | ﹤0.01% | 3367 |
|